Skip to main content

and
  1. Article

    Open Access

    Long-term outcome of children with acute promyelocytic leukemia: a randomized study of oral versus intravenous arsenic by SCCLG-APL group

    Realgar-Indigo naturalis formula (RIF), an oral traditional Chinese medicine mainly containing Realgar (As4S4), is highly effective in treating adult acute promyelocytic leukemia (APL). However, the treatment eff...

    Dan-** Huang, Liang-Chun Yang, Yi-Qiao Chen, Wu-Qing Wan in Blood Cancer Journal (2023)

  2. Article

    Open Access

    A multicenter prospective study on the management of hepatoblastoma in children: a report from the Chinese Children’s Cancer Group

    This study aimed to identify survival risk factors in Chinese children with hepatoblastoma (HB) and assess the effectiveness of the new treatment protocol proposed by the Chinese Children’s Cancer Group (CCCG)...

    Meng-Jie Tang, **ao-Li Ma, **ang-Ling He, Wei-Hua Pan in World Journal of Pediatrics (2023)

  3. No Access

    Article

    A prospective multicenter study investigating rituximab combined with intensive chemotherapy in newly diagnosed pediatric patients with aggressive mature B cell non-Hodgkin lymphoma (CCCG-BNHL-2015): a report from the Chinese Children’s Cancer Group

    The evidence for the safety and efficacy of adding rituximab to intensive chemotherapy in pediatric patients with aggressive mature B cell non-Hodgkin lymphoma/leukemia (B-NHL/B-AL) is not yet robust. In this ...

    Yi-** Gao, Yong-Jun Fang, Ju Gao, Jie Yan, Liang-Chun Yang in Annals of Hematology (2022)